Published in Eur J Gastroenterol Hepatol on September 01, 1996
Lipid peroxidation products and antioxidants in human disease. Environ Health Perspect (1998) 1.56
[Liver biopsy at the intersection of clinical and pathological diagnosis]. Pathologe (2008) 0.75
An experiment to determine the active therapeutic moiety of sulphasalazine. Lancet (1977) 7.89
Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br J Cancer (2001) 5.36
Detection of a novel DNA virus (TTV) in blood donors and blood products. Lancet (1998) 5.15
Should methionine be added to every paracetamol tablet? BMJ (1997) 3.33
Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5' non-coding region. J Gen Virol (1995) 3.10
Variation of the hepatitis C virus 5' non-coding region: implications for secondary structure, virus detection and typing. The International HCV Collaborative Study Group. J Gen Virol (1995) 2.91
Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis. Gut (1980) 2.81
Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score. Gut (2005) 2.62
Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection. Gut (1998) 2.45
Hepatotoxicity of herbal remedies. BMJ (1989) 2.37
UK guidelines on the management of variceal haemorrhage in cirrhotic patients. British Society of Gastroenterology. Gut (2000) 2.33
Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. The International HCV Collaborative Study Group. J Gen Virol (1995) 2.00
Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure. Lancet (1999) 1.89
Review article: omega-3 fatty acids - a promising novel therapy for non-alcoholic fatty liver disease. Aliment Pharmacol Ther (2010) 1.87
Exercise-induced left ventricular dysfunction in alcoholic and non-alcoholic cirrhosis. J Hepatol (1995) 1.84
Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes. Am J Hum Genet (2001) 1.81
p53 expression in colorectal tumors. Am J Pathol (1991) 1.77
Linked DNA markers for presymptomatic diagnosis of familial adenomatous polyposis. Lancet (1991) 1.77
An immunoperoxidase technique for the identification of gastrin-producing cells. J Clin Pathol (1974) 1.71
The outcome of the first 165 orthotopic liver transplants in Scotland. Scott Med J (1999) 1.63
Hepatic encephalopathy and ascites. Lancet (1997) 1.57
Randomised clinical study: comparison of acceptability, patient tolerance, cardiac stress and endoscopic views in transnasal and transoral endoscopy under local anaesthetic. Aliment Pharmacol Ther (2014) 1.54
A comparative study of emergency transjugular intrahepatic portosystemic stent-shunt and esophageal transection in the management of uncontrolled variceal hemorrhage. Am J Gastroenterol (1995) 1.52
Stabilised p53 facilitates aneuploid clonal divergence in colorectal cancer. Oncogene (1993) 1.50
MCC, a candidate familial polyposis gene in 5q.21, shows frequent allele loss in colorectal and lung cancer. Oncogene (1991) 1.49
Review article: the management of acute variceal bleeding. Aliment Pharmacol Ther (2003) 1.49
TIPSS 10 years on. Gut (2000) 1.48
Elevation of intracranial pressure following transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage. J Hepatol (1997) 1.48
The effect of polymorphisms in tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta1 genes in acute hepatic allograft rejection. Transplantation (2000) 1.47
The effect of topical N-acetyl-5-aminosalicylic acid in ulcerative colitis. Scand J Gastroenterol (1980) 1.46
Small bowel strictures after blunt abdominal trauma. Br J Surg (1979) 1.44
Hepatotoxicity of sodium stibogluconate in leishmaniasis. Lancet (1993) 1.42
Survey of type 6 group variants of hepatitis C virus in Southeast Asia by using a core-based genotyping assay. J Clin Microbiol (1996) 1.41
Risk of intentional reversible thrombosis of transjugular intrahepatic portosystemic shunt. Radiology (1995) 1.40
Comparison of disodium cromoglycate and sulphasalazine as maintenance therapy for ulcerative colitis. Lancet (1979) 1.40
The sequential organ failure assessment (SOFA) score is an effective triage marker following staggered paracetamol (acetaminophen) overdose. Aliment Pharmacol Ther (2012) 1.40
A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices. Hepatology (1997) 1.39
The hands in alcoholic liver disease. Am J Gastroenterol (1991) 1.39
Normal venous circulation of the gastroesophageal junction. A route to understanding varices. Gastroenterology (1987) 1.39
Direct measurement of pulsatile insulin secretion from the portal vein in human subjects. J Clin Endocrinol Metab (2000) 1.38
Bleeding ectopic varices in cirrhosis: the role of transjugular intrahepatic portosystemic stent shunts. Aliment Pharmacol Ther (2008) 1.38
CDX1 is an important molecular mediator of Barrett's metaplasia. Proc Natl Acad Sci U S A (2005) 1.34
A quantitative study of the influence of fixation on immunoperoxidase staining of rectal mucosal plasma cells. J Clin Pathol (1980) 1.30
The timing of histological damage following a single challenge with gluten in treated coeliac disease. Q J Med (1981) 1.29
Histopathological grade, mucinous differentiation and DNA ploidy in relation to prognosis in colorectal carcinoma. Histopathology (2000) 1.27
Sodium handling in patients with well compensated cirrhosis is dependent on the severity of liver disease and portal pressure. Gut (2000) 1.20
The role of various cereals in coeliac disease. Q J Med (1978) 1.19
Immunohistochemical detection of the ras oncogene p21 product in an experimental tumour and in human colorectal neoplasms. Br J Cancer (1985) 1.15
Role of angiotensin II in regulation of basal and sympathetically stimulated vascular tone in early and advanced cirrhosis. Gastroenterology (2000) 1.14
Campylobacter colitis. J Clin Pathol (1979) 1.12
Measurement of spleen size and its relation to hypersplenism and portal hemodynamics in portal hypertension due to hepatic cirrhosis. Am J Gastroenterol (1996) 1.12
Gastroesophageal reflux and posterior laryngitis. Ann Otol Rhinol Laryngol (1989) 1.11
Abnormal liver function in common variable immunodeficiency disorders due to nodular regenerative hyperplasia. Clin Exp Immunol (2008) 1.11
Tissue eosinophils in ulcerative colitis. Scand J Gastroenterol (1979) 1.10
UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients. Aliment Pharmacol Ther (2012) 1.10
Pharyngoesophageal dysmotility in globus sensation. Arch Otolaryngol Head Neck Surg (1989) 1.10
Discrimination of hepatitis G virus/GBV-C geographical variants by analysis of the 5' non-coding region. J Gen Virol (1997) 1.09
Reduction in renal blood flow following acute increase in the portal pressure: evidence for the existence of a hepatorenal reflex in man? Gut (1997) 1.09
The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure. Gut (2008) 1.08
Transjugular intrahepatic portosystemic stent shunt (TIPSS): early clinical experience. Clin Radiol (1992) 1.07
Detection in chimpanzees of a novel flavivirus related to GB virus-C/hepatitis G virus. J Gen Virol (1998) 1.06
Detection of enterovirus viraemia in blood donors. Vox Sang (2001) 1.06
Review article: the current management of acute liver failure. Aliment Pharmacol Ther (2009) 1.06
Luminal ions and short chain fatty acids as markers of functional activity of the mucosa in ulcerative colitis. J Clin Pathol (1982) 1.05
Argentaffin cells in ulcerative colitis. Gut (1971) 1.05
Screening for hepatocellular carcinoma. Eur J Gastroenterol Hepatol (1996) 1.04
Peripheral vascular tone in patients with cirrhosis: role of the renin-angiotensin and sympathetic nervous systems. Cardiovasc Res (1998) 1.04
The influence of captopril, the nitrates and propranolol on apparent liver blood flow. Br J Clin Pharmacol (1985) 1.04
Enhanced vasodilatation to endothelin antagonism in patients with compensated cirrhosis and the role of nitric oxide. Gut (2003) 1.04
Haemodynamic parameters predicting variceal haemorrhage and survival in alcoholic cirrhosis. QJM (1998) 1.03
Antigenic variation of core, NS3, and NS5 proteins among genotypes of hepatitis C virus. J Clin Microbiol (1997) 1.02
Age, anemia, and obesity-associated oxygen desaturation during upper gastrointestinal endoscopy. Gastrointest Endosc (1993) 1.01
Altered peripheral vascular responses to exogenous and endogenous endothelin-1 in patients with well-compensated cirrhosis. Hepatology (2001) 1.01
Which hepatocyte will it be? Hepatocyte choice for bioartificial liver support systems. Liver Transpl (2001) 1.01
Animal models of fulminant hepatic failure: a critical evaluation. Liver Transpl (2000) 1.01
Gastin cells and fasting gastrin levels in duodenal ulcer patients: a quantitative study based on multiple biopsy specimens. J Clin Pathol (1979) 1.01
Sexual transmission of GB virus C/hepatitis G virus. J Med Virol (1998) 1.01
A comparison between gastric and oesophageal variceal haemorrhage treated with transjugular intrahepatic portosystemic stent shunt (TIPSS). Aliment Pharmacol Ther (1997) 1.00
Review article: current endoscopic therapeutic options in the management of variceal bleeding. Aliment Pharmacol Ther (2001) 1.00
Haemodynamic effects of acute and chronic administration of low-dose carvedilol, a vasodilating beta-blocker, in patients with cirrhosis and portal hypertension. Aliment Pharmacol Ther (2002) 1.00
Glutathione S-transferase isoenzymes and glutathione peroxidase activity in normal and tumour samples from human lung. Carcinogenesis (1988) 1.00
Evidence of hydrogen ion secretion from the human gall bladder in vitro. Gut (1992) 0.99
Hyperdynamic circulation in liver cirrhosis: not peripheral vasodilatation but 'splanchnic steal'. QJM (2002) 0.99
Transjugular intrahepatic portosystemic stent-shunt (TIPSS): long-term follow-up. QJM (1994) 0.98
Controlled clinical trial of injection sclerotherapy for active variceal bleeding. Hepatology (1989) 0.98
Review article: the management of acute liver failure. Aliment Pharmacol Ther (1998) 0.97
Hyperammonaemia in cirrhosis and Helicobacter pylori infection. Lancet (1995) 0.96
Review article: recent advances in the management of bleeding gastric varices. Aliment Pharmacol Ther (2006) 0.96
Low serum retinol levels are associated with hepatocellular carcinoma in patients with chronic liver disease. Aliment Pharmacol Ther (2000) 0.95
Prevalence, incidence, and clinical characteristics of hepatitis G virus/GB virus C infection in Scottish blood donors. J Infect Dis (1998) 0.95
Association between chronic hepatitis C infection and hepatocellular carcinoma. Lancet (1995) 0.94